HAVANA, Cuba, Aug 13 (ACN) Cuban scientists are progressing in the search for a domestic vaccine against COVID-19, a goal that every day seems to be closer.
To achieve this goal, the Finlay Institute of Vaccines (IFV) has played an essential role in obtaining a candidate to prevent SARS-CoV-2 and provide the country with technological sovereignty in the production and availability of this possible immunogen.
Regarding the subject, Cubadebate spoke with Dagmar Garcia Rivera, director of research at the IFV, about how this process is advancing.
In May we began to work hard on designing what would be a vaccine candidate to prevent infection by the SARS-COV-2 virus, based on the experience we have as an institution in developing preventive vaccines and understanding and knowing the phenomena associated with this particular virus, which is new, the researcher said.
We're talking about a vaccine aimed at preventing the infection of the virus. Therefore, people cannot feel at all that it is the near solution to the pandemic situation we are living in the world and also to the particular situation that the country is still facing, in the course of the epidemic, she continued.
So, it does not replace the measures of physical distancing that have been established by the direction of the Health Ministry, nor can it express an excess of trust in the population, to think that the solution is at hand, Garcia Rivera stated.
Even if we succeed in continuing to make satisfactory progress in research, in this project the clinical development phases are still phases that require a certain amount of time to be able to say that we would have a vaccine that protects or is effective against the disease, the expert concluded.